Reimbursement for

Aquablation® Therapy

Patient reimbursement information may be found on our patient website by clicking here.

PROCEPT BioRobotics® is committed to educating and supporting healthcare professionals about Aquablation reimbursement. This section contains reimbursement information that may be useful for understanding and navigating the insurance process.

United States Reimbursement
Aquablation therapy is a benign prostatic hyperplasia (BPH) surgical therapy that received FDA clearance in December 2017. The Aquablation procedure enjoys widespread insurance coverage by both national and regional insurance payers.

Coverage
Aquablation therapy is covered by Medicare, Medicare Advantage, Tricare, and many commercial insurance plans when medical criteria are met. For more information on health plan specific coverage and medical criteria, please view our online Payer Coverage Lookup Tool.

Prior Authorization – Medicare
Traditional, fee-for-service Medicare does not require prior authorization. Medicare Advantage Plans will likely require a prior authorization.

Prior Authorization – Private Insurance
Private insurers may require prior authorization for Aquablation therapy. Prior authorization requirements vary by payer and patient plan.

Denials and Appeals
Providers and patients have the right to appeal prior authorization denials, claim denials, and insufficient payment. Each payer has a defined appeals process and timely filing requirements. Appeals ensure that patient and provider denial issues are given appropriate consideration and review appeals also may address payer non-coverage.

To Request More Information
To request assistance with reimbursement questions or prior authorization, please contact us directly.

For a copy of the Aquablation Therapy Coding Reference Guide, click here.

Disclaimer:
The information provided in this document was obtained from third-party sources and is subject to change without notice as a result of changes in reimbursement laws, regulations, rules, policies, and payment amounts. All content is general in nature and does not cover all situations or all payers’ rules and policies. It is the responsibility of the hospital or physician to determine medical necessity, the proper site for delivery of any services, and to submit appropriate codes, modifiers, and charges for a particular patient and/or procedure. Any claim should be coded appropriately and supported with adequate documentation in the medical record. Reimbursement policies can vary considerably from one region or payer to another and may change over time. PROCEPT BioRobotics encourages providers to submit claims for services consistent with FDA clearance and approved labeling.